NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹73 Cr | ₹60 Cr | ₹58 Cr | ₹57 Cr | ₹60 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹73 Cr |
Mar2024 | ₹60 Cr |
Mar2023 | ₹58 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹60 Cr |
How is Deferred Tax Assets / Liabilities of NEULAND LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹73 Cr | 20.49 | |
Mar2024 | ₹60 Cr | 3.67 | |
Mar2023 | ₹58 Cr | 2.82 | |
Mar2022 | ₹57 Cr | -5.12 | |
Mar2021 | ₹60 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹16,432.4 Cr | -3.5% | 9.7% | 16.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,734.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -3.5% |
9.7% |
16.9% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses